Myriad Genetics reported $1.26B in Assets for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Assets Change
Accelerate Diagnostics AXDX:US 70.36M 12.69M
Agilent A:US $ 10455M 128M
Becton, Dickinson and BDX:US $ 54786M 1423M
Bio Rad Laboratories BIO:US $ 14373.7M 3402.1M
Biocept BIOC:US $ 61.94M 1.53M
Bruker BRKR:US $ 3550.7M 99.3M
Danaher DHR:US $ 83392M 208M
Exact Sciences EXAS:US $ 6490.54M 194.35M
Fluidigm FLDM:US $ 271.94M 3.28M
Hologic HOLX:US $ 9514.5M 229.4M
Illumina ILMN:US $ 15274M 57M
Johnson & Johnson JNJ:US $ 178355M 3663M
Mettler Toledo International MTD:US 3.36B 29.38M
Myriad Genetics MYGN:US $ 1255.4M 65.3M
Nanostring Technologies NSTG:US $ 444.72M 34.76M
Orasure Technologies OSUR:US $ 435.53M 25.46M
Pacific Biosciences Of California PACB:US $ 1936.67M 70.3M
Perkinelmer PKI:US $ 14848.47M 152.09M
Quest Diagnostics DGX:US $ 13442M 169M
Quidel QDEL:US $ 3093.12M 662.75M
Repligen RGEN:US $ 2383.82M 25.47M
Thermo Fisher Scientific TMO:US $ 92747M 2376M
Veracyte VCYT:US $ 1173.59M 14.24M
Waters WAT:US $ 3041.27M 53.66M